Stock Taper 
CGON
$74.34
▼ DOWN 5.91% (-4.67)
KEY STATISTICS
Market Cap$6.56 B
52w High$80.97
52w Low$26.25
Dividend Yield—
Frequency—
P/E-27.64
Volume612.55K
Shares Out.88.20M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Arthur Kuan
COMPENSATION 2026
Salary$690,000
Stock Awards$3,451,884
Incentive Plan Pay$414,000
All Other Comp.$22,002
Total$11,928,401
ABOUT
SECTOR
Healthcare
WENT PUBLIC
January 25, 2024
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
142
PRICE TARGET
Target High$100.00
Target Low$80.00
Target Median$85.00
Target Consensus$87.20
UPCOMING EARNINGS
DateNov 13, 2026
DayFriday
Rev. Est.$547.68K
NOV
13
FRI
PRICE
$74.34 ▼ DOWN 5.91% (−$4.67)About CG Oncology Inc.
https://cgoncology.com ↗CG Oncology Inc is a biopharmaceutical company developing cretostimogene, a bladder-sparing therapy for high-risk Non-Muscle Invasive Bladder Cancer patients unresponsive to BCG therapy.
INDUSTRY
Biotechnology
A PRODUCT CG ONCOLOGY INC. IS KNOWN FOR
Cretostimogene Grenadenorepvec
Cretostimogene grenadenorepvec is an investigational, intravesical oncolytic immunotherapy for high-risk NMIBC, in late-stage trials with FDA Fast Track and Breakthrough designations, aiming to selectively destroy cancer cells and stimulate immune...
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | License And Collaboration Revenue | $158K | $648K ▲ | $14K ▼ | $10K ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
157
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
69.50%
HOLDERS
294
TOP 12 OF 294 · RANKED BY POSITION SIZE
Rtw Investments, LP
T. Rowe Price Investment Management, Inc.
Vanguard Group Inc
Decheng Capital LLC
Blackrock, Inc.
Wellington Management Group Llp
Fmr LLC
Price T Rowe Associates Inc /Md/
Tcg Crossover Management, LLC
State Street Corp
Braidwell LP
Foresite Capital Management Vi LLC
RATINGS SNAPSHOT
Overall rating: C-
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
DIRECTOR
POST LEONARD E
Purchase · 1.0K shares
2026-08-14
★
DIRECTOR
POST LEONARD E
Sale · 1.0K shares
2026-08-14
★
DIRECTOR
POST LEONARD E
Sale · 1.0K shares
2026-07-15
★
DIRECTOR
POST LEONARD E
Purchase · 1.0K shares
2026-07-15
MOST RECENT ANALYST GRADES
GRADE SUMMARY
OVERWEIGHT 4
OUTPERFORM 2
BUY 2
8 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 APGE | $134.97 | COMPARE |
 TVTX | $65.67 | COMPARE |
 XENE | $59.99 | COMPARE |
 CELC | $88.44 | COMPARE |
 LEGN | $19.88 | COMPARE |
 TARS | $71.76 | COMPARE |
 IRON | $80.03 | COMPARE |
 RARE | $25.61 | COMPARE |